img

Global Radiation Emergency Medications Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Radiation Emergency Medications Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Radiation emergency medications are pharmaceuticals used to treat individuals exposed to ionizing radiation during radiological or nuclear emergencies. Exposure to high levels of ionizing radiation can occur in incidents such as nuclear accidents, radiological attacks, or industrial accidents involving radioactive materials. Radiation can cause severe damage to cells and tissues, leading to acute radiation syndrome (ARS) or radiation sickness.
These medications aim to protect cells and tissues from the harmful effects of radiation. They can help minimize radiation-induced damage by scavenging free radicals and reducing oxidative stress. They can help reduce the severity of symptoms and improve outcomes for individuals exposed to radiation.
Global Radiation Emergency Medications market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Acute Radiation Syndrome(ARS) and Cancer Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Radiation Emergency Medications industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Radiation Emergency Medications key manufacturers include Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics and Mission Pharmacal, etc. Amgen, Anbex, BTG International are top 3 players and held % sales share in total in 2022.
Radiation Emergency Medications can be divided into Potassium lodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate) and Others, etc. Potassium lodide (KI) is the mainstream product in the market, accounting for % sales share globally in 2022.
Radiation Emergency Medications is widely used in various fields, such as Acute Radiation Syndrome(ARS), Cancer Treatment, Radiation Exposure and Others, etc. Acute Radiation Syndrome(ARS) provides greatest supports to the Radiation Emergency Medications industry development. In 2022, global % sales of Radiation Emergency Medications went into Acute Radiation Syndrome(ARS) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Radiation Emergency Medications market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen
Anbex
BTG International
Cellphire
Chrysalis BioTherapeutics
Darnitsa
Enzychem Lifesciences
Humanetics
Mission Pharmacal
Partner Therapeutics
Myelo Therapeutics
Pluri
Segment by Type
Potassium lodide (KI)
Prussian Blue
DTPA (Diethylenetriamine Pentaacetate)
Others

Segment by Application


Acute Radiation Syndrome(ARS)
Cancer Treatment
Radiation Exposure
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Radiation Emergency Medications market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Radiation Emergency Medications, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Radiation Emergency Medications industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Radiation Emergency Medications in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Radiation Emergency Medications introduction, etc. Radiation Emergency Medications Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Radiation Emergency Medications market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Radiation Emergency Medications Market Overview
1.1 Radiation Emergency Medications Product Overview
1.2 Radiation Emergency Medications Market Segment by Type
1.2.1 Potassium lodide (KI)
1.2.2 Prussian Blue
1.2.3 DTPA (Diethylenetriamine Pentaacetate)
1.2.4 Others
1.3 Global Radiation Emergency Medications Market Size by Type
1.3.1 Global Radiation Emergency Medications Market Size Overview by Type (2018-2029)
1.3.2 Global Radiation Emergency Medications Historic Market Size Review by Type (2018-2024)
1.3.3 Global Radiation Emergency Medications Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiation Emergency Medications Sales Breakdown by Type (2018-2024)
1.4.2 Europe Radiation Emergency Medications Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Radiation Emergency Medications Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Radiation Emergency Medications Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Radiation Emergency Medications Sales Breakdown by Type (2018-2024)
2 Global Radiation Emergency Medications Market Competition by Company
2.1 Global Top Players by Radiation Emergency Medications Sales (2018-2024)
2.2 Global Top Players by Radiation Emergency Medications Revenue (2018-2024)
2.3 Global Top Players by Radiation Emergency Medications Price (2018-2024)
2.4 Global Top Manufacturers Radiation Emergency Medications Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiation Emergency Medications Market Competitive Situation and Trends
2.5.1 Radiation Emergency Medications Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiation Emergency Medications Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiation Emergency Medications as of 2022)
2.7 Date of Key Manufacturers Enter into Radiation Emergency Medications Market
2.8 Key Manufacturers Radiation Emergency Medications Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Radiation Emergency Medications Status and Outlook by Region
3.1 Global Radiation Emergency Medications Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Radiation Emergency Medications Historic Market Size by Region
3.2.1 Global Radiation Emergency Medications Sales in Volume by Region (2018-2024)
3.2.2 Global Radiation Emergency Medications Sales in Value by Region (2018-2024)
3.2.3 Global Radiation Emergency Medications Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Radiation Emergency Medications Forecasted Market Size by Region
3.3.1 Global Radiation Emergency Medications Sales in Volume by Region (2024-2029)
3.3.2 Global Radiation Emergency Medications Sales in Value by Region (2024-2029)
3.3.3 Global Radiation Emergency Medications Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Radiation Emergency Medications by Application
4.1 Radiation Emergency Medications Market Segment by Application
4.1.1 Acute Radiation Syndrome(ARS)
4.1.2 Cancer Treatment
4.1.3 Radiation Exposure
4.1.4 Others
4.2 Global Radiation Emergency Medications Market Size by Application
4.2.1 Global Radiation Emergency Medications Market Size Overview by Application (2018-2029)
4.2.2 Global Radiation Emergency Medications Historic Market Size Review by Application (2018-2024)
4.2.3 Global Radiation Emergency Medications Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiation Emergency Medications Sales Breakdown by Application (2018-2024)
4.3.2 Europe Radiation Emergency Medications Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Radiation Emergency Medications Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Radiation Emergency Medications Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Radiation Emergency Medications Sales Breakdown by Application (2018-2024)
5 North America Radiation Emergency Medications by Country
5.1 North America Radiation Emergency Medications Historic Market Size by Country
5.1.1 North America Radiation Emergency Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Radiation Emergency Medications Sales in Volume by Country (2018-2024)
5.1.3 North America Radiation Emergency Medications Sales in Value by Country (2018-2024)
5.2 North America Radiation Emergency Medications Forecasted Market Size by Country
5.2.1 North America Radiation Emergency Medications Sales in Volume by Country (2024-2029)
5.2.2 North America Radiation Emergency Medications Sales in Value by Country (2024-2029)
6 Europe Radiation Emergency Medications by Country
6.1 Europe Radiation Emergency Medications Historic Market Size by Country
6.1.1 Europe Radiation Emergency Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Radiation Emergency Medications Sales in Volume by Country (2018-2024)
6.1.3 Europe Radiation Emergency Medications Sales in Value by Country (2018-2024)
6.2 Europe Radiation Emergency Medications Forecasted Market Size by Country
6.2.1 Europe Radiation Emergency Medications Sales in Volume by Country (2024-2029)
6.2.2 Europe Radiation Emergency Medications Sales in Value by Country (2024-2029)
7 Asia-Pacific Radiation Emergency Medications by Region
7.1 Asia-Pacific Radiation Emergency Medications Historic Market Size by Region
7.1.1 Asia-Pacific Radiation Emergency Medications Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Radiation Emergency Medications Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Radiation Emergency Medications Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Radiation Emergency Medications Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiation Emergency Medications Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Radiation Emergency Medications Sales in Value by Region (2024-2029)
8 Latin America Radiation Emergency Medications by Country
8.1 Latin America Radiation Emergency Medications Historic Market Size by Country
8.1.1 Latin America Radiation Emergency Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Radiation Emergency Medications Sales in Volume by Country (2018-2024)
8.1.3 Latin America Radiation Emergency Medications Sales in Value by Country (2018-2024)
8.2 Latin America Radiation Emergency Medications Forecasted Market Size by Country
8.2.1 Latin America Radiation Emergency Medications Sales in Volume by Country (2024-2029)
8.2.2 Latin America Radiation Emergency Medications Sales in Value by Country (2024-2029)
9 Middle East and Africa Radiation Emergency Medications by Country
9.1 Middle East and Africa Radiation Emergency Medications Historic Market Size by Country
9.1.1 Middle East and Africa Radiation Emergency Medications Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Radiation Emergency Medications Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Radiation Emergency Medications Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Radiation Emergency Medications Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiation Emergency Medications Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Radiation Emergency Medications Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Radiation Emergency Medications Products Offered
10.1.5 Amgen Recent Development
10.2 Anbex
10.2.1 Anbex Company Information
10.2.2 Anbex Introduction and Business Overview
10.2.3 Anbex Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Anbex Radiation Emergency Medications Products Offered
10.2.5 Anbex Recent Development
10.3 BTG International
10.3.1 BTG International Company Information
10.3.2 BTG International Introduction and Business Overview
10.3.3 BTG International Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.3.4 BTG International Radiation Emergency Medications Products Offered
10.3.5 BTG International Recent Development
10.4 Cellphire
10.4.1 Cellphire Company Information
10.4.2 Cellphire Introduction and Business Overview
10.4.3 Cellphire Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cellphire Radiation Emergency Medications Products Offered
10.4.5 Cellphire Recent Development
10.5 Chrysalis BioTherapeutics
10.5.1 Chrysalis BioTherapeutics Company Information
10.5.2 Chrysalis BioTherapeutics Introduction and Business Overview
10.5.3 Chrysalis BioTherapeutics Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Chrysalis BioTherapeutics Radiation Emergency Medications Products Offered
10.5.5 Chrysalis BioTherapeutics Recent Development
10.6 Darnitsa
10.6.1 Darnitsa Company Information
10.6.2 Darnitsa Introduction and Business Overview
10.6.3 Darnitsa Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Darnitsa Radiation Emergency Medications Products Offered
10.6.5 Darnitsa Recent Development
10.7 Enzychem Lifesciences
10.7.1 Enzychem Lifesciences Company Information
10.7.2 Enzychem Lifesciences Introduction and Business Overview
10.7.3 Enzychem Lifesciences Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Enzychem Lifesciences Radiation Emergency Medications Products Offered
10.7.5 Enzychem Lifesciences Recent Development
10.8 Humanetics
10.8.1 Humanetics Company Information
10.8.2 Humanetics Introduction and Business Overview
10.8.3 Humanetics Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Humanetics Radiation Emergency Medications Products Offered
10.8.5 Humanetics Recent Development
10.9 Mission Pharmacal
10.9.1 Mission Pharmacal Company Information
10.9.2 Mission Pharmacal Introduction and Business Overview
10.9.3 Mission Pharmacal Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Mission Pharmacal Radiation Emergency Medications Products Offered
10.9.5 Mission Pharmacal Recent Development
10.10 Partner Therapeutics
10.10.1 Partner Therapeutics Company Information
10.10.2 Partner Therapeutics Introduction and Business Overview
10.10.3 Partner Therapeutics Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Partner Therapeutics Radiation Emergency Medications Products Offered
10.10.5 Partner Therapeutics Recent Development
10.11 Myelo Therapeutics
10.11.1 Myelo Therapeutics Company Information
10.11.2 Myelo Therapeutics Introduction and Business Overview
10.11.3 Myelo Therapeutics Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Myelo Therapeutics Radiation Emergency Medications Products Offered
10.11.5 Myelo Therapeutics Recent Development
10.12 Pluri
10.12.1 Pluri Company Information
10.12.2 Pluri Introduction and Business Overview
10.12.3 Pluri Radiation Emergency Medications Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Pluri Radiation Emergency Medications Products Offered
10.12.5 Pluri Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiation Emergency Medications Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiation Emergency Medications Industrial Chain Analysis
11.4 Radiation Emergency Medications Market Dynamics
11.4.1 Radiation Emergency Medications Industry Trends
11.4.2 Radiation Emergency Medications Market Drivers
11.4.3 Radiation Emergency Medications Market Challenges
11.4.4 Radiation Emergency Medications Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiation Emergency Medications Distributors
12.3 Radiation Emergency Medications Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Potassium lodide (KI)
Table 2. Major Company of Prussian Blue
Table 3. Major Company of DTPA (Diethylenetriamine Pentaacetate)
Table 4. Major Company of Others
Table 5. Global Radiation Emergency Medications Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 7. Global Radiation Emergency Medications Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Radiation Emergency Medications Sales by Type (2018-2024) & (US& Million)
Table 9. Global Radiation Emergency Medications Market Share in Value by Type (2018-2024)
Table 10. Global Radiation Emergency Medications Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Radiation Emergency Medications Sales by Type (2024-2029) & (K Units)
Table 12. Global Radiation Emergency Medications Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Radiation Emergency Medications Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Radiation Emergency Medications Sales Market Share in Value by Type (2024-2029)
Table 15. Global Radiation Emergency Medications Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Radiation Emergency Medications Sales by Type (2018-2024) & (K Units)
Table 17. North America Radiation Emergency Medications Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Radiation Emergency Medications Sales (K Units) by Type (2018-2024)
Table 19. Europe Radiation Emergency Medications Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Radiation Emergency Medications Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Radiation Emergency Medications Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Radiation Emergency Medications Sales (K Units) by Type (2018-2024)
Table 23. Latin America Radiation Emergency Medications Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Radiation Emergency Medications Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Radiation Emergency Medications Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Radiation Emergency Medications Sales by Company (2018-2024) & (K Units)
Table 27. Global Radiation Emergency Medications Sales Share by Company (2018-2024)
Table 28. Global Radiation Emergency Medications Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Radiation Emergency Medications Revenue Share by Company (2018-2024)
Table 30. Global Market Radiation Emergency Medications Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Radiation Emergency Medications Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Radiation Emergency Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiation Emergency Medications as of 2022)
Table 34. Date of Key Manufacturers Enter into Radiation Emergency Medications Market
Table 35. Key Manufacturers Radiation Emergency Medications Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Radiation Emergency Medications Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Radiation Emergency Medications Sales by Region (2018-2024) & (K Units)
Table 39. Global Radiation Emergency Medications Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Radiation Emergency Medications Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Radiation Emergency Medications Sales Market Share in Value by Region (2018-2024)
Table 42. Global Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Radiation Emergency Medications Sales by Region (2024-2029) & (K Units)
Table 44. Global Radiation Emergency Medications Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Radiation Emergency Medications Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Radiation Emergency Medications Sales Market Share in Value by Region (2024-2029)
Table 47. Global Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Radiation Emergency Medications Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Radiation Emergency Medications Sales by Application (2018-2024) & (K Units)
Table 50. Global Radiation Emergency Medications Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Radiation Emergency Medications Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Radiation Emergency Medications Sales Market Share in Value by Application (2018-2024)
Table 53. Global Radiation Emergency Medications Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Radiation Emergency Medications Sales by Application (2024-2029) & (K Units)
Table 55. Global Radiation Emergency Medications Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Radiation Emergency Medications Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Radiation Emergency Medications Sales Market Share in Value by Application (2024-2029)
Table 58. Global Radiation Emergency Medications Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Radiation Emergency Medications Sales by Application (2018-2024) (K Units)
Table 60. North America Radiation Emergency Medications Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Radiation Emergency Medications Sales by Application (2018-2024) (K Units)
Table 62. Europe Radiation Emergency Medications Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Radiation Emergency Medications Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Radiation Emergency Medications Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Radiation Emergency Medications Sales by Application (2018-2024) (K Units)
Table 66. Latin America Radiation Emergency Medications Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Radiation Emergency Medications Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Radiation Emergency Medications Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 70. North America Radiation Emergency Medications Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Radiation Emergency Medications Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Radiation Emergency Medications Sales Market Share in Value by Country (2018-2024)
Table 73. North America Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 74. North America Radiation Emergency Medications Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Radiation Emergency Medications Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Radiation Emergency Medications Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 78. Europe Radiation Emergency Medications Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Radiation Emergency Medications Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Radiation Emergency Medications Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 82. Europe Radiation Emergency Medications Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Radiation Emergency Medications Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Radiation Emergency Medications Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Radiation Emergency Medications Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Radiation Emergency Medications Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Radiation Emergency Medications Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Radiation Emergency Medications Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Radiation Emergency Medications Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Radiation Emergency Medications Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Radiation Emergency Medications Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Radiation Emergency Medications Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Radiation Emergency Medications Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Radiation Emergency Medications Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Radiation Emergency Medications Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Radiation Emergency Medications Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Radiation Emergency Medications Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Radiation Emergency Medications Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Radiation Emergency Medications Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Radiation Emergency Medications Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Radiation Emergency Medications Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Radiation Emergency Medications Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Radiation Emergency Medications Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Radiation Emergency Medications Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Radiation Emergency Medications Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Radiation Emergency Medications Sales Market Share in Value by Country (2024-2029)
Table 109. Amgen Company Information
Table 110. Amgen Introduction and Business Overview
Table 111. Amgen Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Amgen Radiation Emergency Medications Product
Table 113. Amgen Recent Development
Table 114. Anbex Company Information
Table 115. Anbex Introduction and Business Overview
Table 116. Anbex Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Anbex Radiation Emergency Medications Product
Table 118. Anbex Recent Development
Table 119. BTG International Company Information
Table 120. BTG International Introduction and Business Overview
Table 121. BTG International Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. BTG International Radiation Emergency Medications Product
Table 123. BTG International Recent Development
Table 124. Cellphire Company Information
Table 125. Cellphire Introduction and Business Overview
Table 126. Cellphire Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Cellphire Radiation Emergency Medications Product
Table 128. Cellphire Recent Development
Table 129. Chrysalis BioTherapeutics Company Information
Table 130. Chrysalis BioTherapeutics Introduction and Business Overview
Table 131. Chrysalis BioTherapeutics Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Chrysalis BioTherapeutics Radiation Emergency Medications Product
Table 133. Chrysalis BioTherapeutics Recent Development
Table 134. Darnitsa Company Information
Table 135. Darnitsa Introduction and Business Overview
Table 136. Darnitsa Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Darnitsa Radiation Emergency Medications Product
Table 138. Darnitsa Recent Development
Table 139. Enzychem Lifesciences Company Information
Table 140. Enzychem Lifesciences Introduction and Business Overview
Table 141. Enzychem Lifesciences Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Enzychem Lifesciences Radiation Emergency Medications Product
Table 143. Enzychem Lifesciences Recent Development
Table 144. Humanetics Company Information
Table 145. Humanetics Introduction and Business Overview
Table 146. Humanetics Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Humanetics Radiation Emergency Medications Product
Table 148. Humanetics Recent Development
Table 149. Mission Pharmacal Company Information
Table 150. Mission Pharmacal Introduction and Business Overview
Table 151. Mission Pharmacal Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Mission Pharmacal Radiation Emergency Medications Product
Table 153. Mission Pharmacal Recent Development
Table 154. Partner Therapeutics Company Information
Table 155. Partner Therapeutics Introduction and Business Overview
Table 156. Partner Therapeutics Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Partner Therapeutics Radiation Emergency Medications Product
Table 158. Partner Therapeutics Recent Development
Table 159. Myelo Therapeutics Company Information
Table 160. Myelo Therapeutics Introduction and Business Overview
Table 161. Myelo Therapeutics Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Myelo Therapeutics Radiation Emergency Medications Product
Table 163. Myelo Therapeutics Recent Development
Table 164. Pluri Company Information
Table 165. Pluri Introduction and Business Overview
Table 166. Pluri Radiation Emergency Medications Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Pluri Radiation Emergency Medications Product
Table 168. Pluri Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Radiation Emergency Medications Market Trends
Table 172. Radiation Emergency Medications Market Drivers
Table 173. Radiation Emergency Medications Market Challenges
Table 174. Radiation Emergency Medications Market Restraints
Table 175. Radiation Emergency Medications Distributors List
Table 176. Radiation Emergency Medications Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiation Emergency Medications Product Picture
Figure 2. Global Radiation Emergency Medications Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Radiation Emergency Medications Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Radiation Emergency Medications Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Potassium lodide (KI)
Figure 6. Global Potassium lodide (KI) Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Prussian Blue
Figure 8. Global Prussian Blue Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of DTPA (Diethylenetriamine Pentaacetate)
Figure 10. Global DTPA (Diethylenetriamine Pentaacetate) Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Radiation Emergency Medications Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Radiation Emergency Medications Sales Market Share by Type in 2022 & 2029
Figure 15. North America Radiation Emergency Medications Sales Market Share in Volume by Type in 2022
Figure 16. North America Radiation Emergency Medications Sales Market Share in Value by Type in 2022
Figure 17. Europe Radiation Emergency Medications Sales Market Share in Volume by Type in 2022
Figure 18. Europe Radiation Emergency Medications Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Radiation Emergency Medications Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Radiation Emergency Medications Sales Market Share in Value by Type in 2022
Figure 21. Latin America Radiation Emergency Medications Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Radiation Emergency Medications Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Radiation Emergency Medications Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Radiation Emergency Medications Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiation Emergency Medications Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiation Emergency Medications Revenue in 2022
Figure 27. Radiation Emergency Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Acute Radiation Syndrome(ARS)
Figure 29. Global Acute Radiation Syndrome(ARS) Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Cancer Treatment
Figure 31. Global Cancer Treatment Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Radiation Exposure
Figure 33. Global Radiation Exposure Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Radiation Emergency Medications Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Radiation Emergency Medications Sales Market Share by Application in 2022 & 2029
Figure 38. North America Radiation Emergency Medications Sales Market Share in Volume by Application in 2022
Figure 39. North America Radiation Emergency Medications Sales Market Share in Value by Application in 2022
Figure 40. Europe Radiation Emergency Medications Sales Market Share in Volume by Application in 2022
Figure 41. Europe Radiation Emergency Medications Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Radiation Emergency Medications Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Radiation Emergency Medications Sales Market Share in Value by Application in 2022
Figure 44. Latin America Radiation Emergency Medications Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Radiation Emergency Medications Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Radiation Emergency Medications Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Radiation Emergency Medications Manufacturing Cost Structure
Figure 49. Radiation Emergency Medications Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries